Number of the records: 1
Epigenetics in breast cancer therapy - new strategies and future nanomedicine perspectives
Title Epigenetics in breast cancer therapy - new strategies and future nanomedicine perspectives Author Buociková Verona SAVEXONK ; SAVBIOMED - Ústav experimentálnej onkológie SAV Co-authors Rios-Mondragon Ivan Pilalis Eleftherios Chatziioannou Aristotelis Miklíková Svetlana 1988- SAVEXONK ; SAVBIOMED - Ústav experimentálnej onkológie SAV SCOPUS ORCID Mego Michal Pajuste Karlis Rucins Martins Yamani Naouale El Longhin Eleonora Marta Sobolev Arkadij Freixanet M. Plotniece Aiva Dušinská Mária Cimpan M. R. Gábelová Alena 1955- SAVEXONK ; SAVBIOMED - Ústav experimentálnej onkológie SAV SCOPUS ORCID Smolková Božena 1968- SAVEXONK ; SAVBIOMED - Ústav experimentálnej onkológie SAV SCOPUS RID ORCID Source document Cancers. Vol. 12 (2020), art. no. 3622 Language eng - English Note open access Document kind rozpis článkov z periodík (rbx) Citations GIANNI, C. - PALLESCHI, M. - MERLONI, F. - DI MENNA, G. - SIRICO, M. - SARTI, S. - VIRGA, A. - ULIVI, P. - CECCONETTO, L. - MARIOTTI, M. - DE GIORGI, U. Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. ISSN 1661-6596, NOV 2022, vol. 23, no. 22. Dostupné na: https://doi.org/10.3390/ijms232214197. SENGUPTA, P. - CHOUDHURY, H. - DUTTA, S. - JACOB, S. - KESHARWANI, P. - GORAIN, B. Current Strategies in Breast Cancer Therapy: Role of Epigenetics and Nanomedicine. In PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION. ISSN 0934-0866, JUL 2022, vol. 39, no. 7. Dostupné na: https://doi.org/10.1002/ppsc.202100276. BALBUENA-REBOLLEDO, I. - RIVERA-ANTONIO, A.M. - SIXTO-LóPEZ, Y. - CORREA-BASURTO, J. - ROSALES-HERNáNDEZ, M.C. - MENDIETA-WEJEBE, J.E. - MARTíNEZ-MARTíNEZ, F.J. - OLIVARES-CORICHI, I.M. - GARCíA-SáNCHEZ, J.R. - GUEVARA-SALAZAR, J.A. - BELLO, M. - PADILLA-MARTíNEZ, I.I. Dihydropyrazole-Carbohydrazide Derivatives with Dual Activity as Antioxidant and Anti-Proliferative Drugs on Breast Cancer Targeting the HDAC6. In PHARMACEUTICALS. JUN 2022, vol. 15, no. 6. Dostupné na: https://doi.org/10.3390/ph15060690. ALEXANDROVA, E. - SALVATI, A. - PECORARO, G. - LAMBERTI, J. - MELONE, V. - SELLITTO, A. - RIZZO, F. - GIURATO, G. - TARALLO, R. - NASSA, G. - WEISZ, A. Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors. In FRONTIERS IN GENETICS. APR 13 2022, vol. 13. Dostupné na: https://doi.org/10.3389/fgene.2022.864612. TARHONSKA, K. - LESICKA, M. - JANASIK, B. - ROSZAK, J. - RESZKA, E. - BRAUN, M. - KOLACINSKA-WOW, A. - JABLONSKA, E. Cadmium and breast cancer-Current state and research gaps in the underlying mechanisms. In TOXICOLOGY LETTERS. ISSN 0378-4274, MAY 15 2022, vol. 361, p. 29-42. Dostupné na: https://doi.org/10.1016/j.toxlet.2022.03.003. CHEN, J.Y. - ZHUANG, Y.X. - WANG, P. - NING, J.F. - LIU, W. - HUANG, Y.T. - LIN, X.Q. - PENG, L. - ZHANG, D.H. Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors. In CELL DEATH & DISEASE. ISSN 2041-4889, MAR 7 2022, vol. 13, no. 3. Dostupné na: https://doi.org/10.1038/s41419-022-04661-8. CELESNIK, H. - POTOCNIK, U. Peripheral Blood Transcriptome in Breast Cancer Patients as a Source of Less Invasive Immune Biomarkers for Personalized Medicine, and Implications for Triple Negative Breast Cancer. In CANCERS. FEB 2022, vol. 14, no. 3. Dostupné na: https://doi.org/10.3390/cancers14030591. PAUL, P. - CHACKO, L. - DUA, T.K. - CHAKRABORTY, P. - PAUL, U. - PHULCHAND, V.V. - JHA, N.K. - JHA, S.K. - KANDIMALLA, R. - DEWANJEE, S. Nanomedicines for the management of diabetic nephropathy: present progress and prospects. In FRONTIERS IN ENDOCRINOLOGY. ISSN 1664-2392, NOV 3 2023, vol. 14. Dostupné na: https://doi.org/10.3389/fendo.2023.1236686. MANNA, P.R. - YANG, S.P. - REDDY, P.H. Epigenetic Dysregulation and Its Correlation with the Steroidogenic Machinery Impacting Breast Pathogenesis: Data Mining and Molecular Insights into Therapeutics. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. ISSN 1661-6596, NOV 2023, vol. 24, no. 22. Dostupné na: https://doi.org/10.3390/ijms242216488. GHOSH, A. - HIMAJA, A. - BISWAS, S. - KULKARNI, O. - GHOSH, B. Advances in the Delivery and Development of Epigenetic Therapeutics for the Treatment of Cancer. In MOLECULAR PHARMACEUTICS. ISSN 1543-8384, OCT 30 2023, vol. 20, no. 12, p. 5981-6009. Dostupné na: https://doi.org/10.1021/acs.molpharmaceut.3c00610. FARANI, M.R. - SARLAK, M. - GHOLAMI, A. - AZARAIAN, M. - BINABAJ, M.M. - KAKAVANDI, S. - TAMBUWALA, M.M. - TAHERIAZAM, A. - HASHEMI, M. - GHASEMI, S. Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?. In PATHOLOGY RESEARCH AND PRACTICE. ISSN 0344-0338, AUG 2023, vol. 248. Dostupné na: https://doi.org/10.1016/j.prp.2023.154688. SINGH, D. - KHAN, M.A. - SIDDIQUE, H.R. Role of epigenetic drugs in sensitizing cancers to anticancer therapies: emerging trends and clinical advancements. In EPIGENOMICS. ISSN 1750-1911, APR 2023, vol. 15, no. 8, p. 517-537. Dostupné na: https://doi.org/10.2217/epi-2023-0142. CHEN, K. - BEERAKA, N.M. - ZHANG, X.L. - SINELNIKOV, M.Y. - PLOTNIKOVA, M. - ZHAO, C.P. - BASAVARAJ, V. - ZHANG, J. - LU, P.W. Recent Advances in Therapeutic Modalities Against Breast Cancer-Related Lymphedema: Future Epigenetic Landscape. In LYMPHATIC RESEARCH AND BIOLOGY. ISSN 1539-6851, DEC 1 2023, vol. 21, no. 6, p. 536-548. Dostupné na: https://doi.org/10.1089/lrb.2022.0016. DAWOUD, A. - ZAKARIA, Z.I. - RASHWAN, H.H. - BRAOUDAKI, M. - YOUNESS, R.A. Circular RNAs: New layer of complexity evading breast cancer heterogeneity. In NON-CODING RNA RESEARCH. ISSN 2468-2160, MAR 2023, vol. 8, no. 1, p. 60-74. Dostupné na: https://doi.org/10.1016/j.ncrna.2022.09.011. KIM, A. - MO, K. - KWON, H. - CHOE, S. - PARK, M. - KWAK, W. - YOON, H. Epigenetic Regulation in Breast Cancer: Insights on Epidrugs. In EPIGENOMES. MAR 2023, vol. 7, no. 1. Dostupné na: https://doi.org/10.3390/epigenomes7010006. APPIAH, C.O. - SINGH, M. - MAY, L. - BAKSHI, I. - VAIDYANATHAN, A. - DENT, P. - GINDER, G. - GRANT, S. - BEAR, H. - LANDRY, J. The epigenetic regulation of cancer cell recovery from therapy exposure and its implications as a novel therapeutic strategy for preventing disease recurrence. In EPIGENETIC REGULATION OF CANCER IN RESPONSE TO CHEMOTHERAPY. ISSN 0065-230X, 2023, vol. 158, p. 337-385. Dostupné na: https://doi.org/10.1016/bs.acr.2022.11.001. KENANOGLU, S. - YüKSEL, E.B. - DüNDAR, M. Current Advances in Breast Cancer: Implications for Developing New Treatment Strategies Through Epi-Drugs on the Road to Modifying the Epigenome. In JOURNAL OF CLINICAL PRACTICE AND RESEARCH. 2023, vol. 45, no. 5, p. 427-434. Dostupné na: https://doi.org/10.14744/cpr.2023.08208. OMOTESHO, Quadri Ajibola - ESCAMILLA, Alejandro - PÉREZ-RUIZ, Elisabeth - FRECHA, Cecilia A. - RUEDA-DOMÍNGUEZ, Antonio - BARRAGÁN, Isabel. Epigenetic targets to enhance antitumor immune response through the induction of tertiary lymphoid structures. In Frontiers in Immunology, 2024-01-01, 15, pp. Dostupné na: https://doi.org/10.3389/fimmu.2024.1348156. KHAN, Tanisha Tabassum Sayka - SHEIKH, Zara - MALEKNIA, Simin - OVEISSI, Farshad - FATHI, Ali - ABRAMS, Terence - ONG, Hui Xin - TRAINI, Daniela. Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges. In Expert Opinion on Drug Delivery, 2024-01-01, 21, 7, pp. 1081-1101. ISSN 17425247. Dostupné na: https://doi.org/10.1080/17425247.2024.2387110. SANEI, Maryam - AMIRHEIDARI, Bagher - SATARZADEH, Naghmeh. Mutuality of epigenetic and nanoparticles: two sides of a coin. In Heliyon, 2024-01-15, 10, 1, pp. ISSN 24058440. Dostupné na: https://doi.org/10.1016/j.heliyon.2023.e23679. PRABHU, Kirti S. - SADIDA, Hana Q. - KUTTIKRISHNAN, Shilpa - JUNEJO, Kulsoom - BHAT, Ajaz A. - UDDIN, Shahab. Beyond genetics: Exploring the role of epigenetic alterations in breast cancer. In Pathology Research and Practice, 2024-02-01, 254, pp. ISSN 03440338. Dostupné na: https://doi.org/10.1016/j.prp.2024.155174. SHEN, Hsieh Tsung - HUNG, Chin Sheng - DAVIS, Clilia - SU, Chih Ming - LIAO, Li Min - SHIH, Hsiu Ming - LEE, Kuan Der - ANSAR, Muhamad - LIN, Ruo Kai. Hypermethylation of the Gene Body in SRCIN1 Is Involved in Breast Cancer Cell Proliferation and Is a Potential Blood-Based Biomarker for Early Detection and a Poor Prognosis. In Biomolecules, 2024-05-01, 14, 5, pp. Dostupné na: https://doi.org/10.3390/biom14050571. KARATAŞ, Ela Tuğrul - KARATAŞ, Muhammet Osman - ÖZDEN, Sibel. Biomarkers in Breast Cancer Epigenetics: Effect of Environmental Factors. In Hacettepe University Journal of the Faculty of Pharmacy, 2024-06-01, 44, 2, pp. 165-181. ISSN 13000608. Dostupné na: https://doi.org/10.52794/hujpharm.1424049. Category ADMA - Scientific papers in foreign impacted journals registered in Web of Sciences or Scopus Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2020 Registered in WOS Registered in SCOPUS DOI 10.3390/cancers12123622 
article
File name Access Size Downloaded Type License Epigenetics in breast cancer therapy - new strategies and future nanomedicine perspectives.pdf available 1.3 MB 6 Publisher's version rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore N rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2020 2019 6.126 Q1 1.938 Q1
Number of the records: 1